On Wednesday, pharma giant AbbVie announced a $1.4 billion investment to build a 185-acre pharmaceutical manufacturing campus ...

AbbVie Inc. ABBV shares are down during Friday’s premarket session following a Complete Response Letter (CRL) from the FDA ...

According to a latest market analysis by Future Market Insights, the global pharmaceutical intermediates market is witnessing ...

AbbVie today announced a $1.4 billion investment to build a new drug production facility on a 185-acre campus in Durham County, where the company expects to employ 734 people. The company’s ...

Pharmaceutical companies participating in the US Food and Drug Administration (FDA) Quality Maturity Pilot (QMM) program ...

The FDA began accepting requests Feb. 1 to participate in its PreCheck pilot program, an initiative aimed at streamlining regulatory review for new U.S.-based pharmaceutical manufacturing facilities.

April 22 (Reuters) - AbbVie will invest $1.4 billion to build a manufacturing campus in North Carolina, the drugmaker said on ...

The US Food and Drug Administration (FDA) has issued warning letters to several drug manufacturers and compounders for ...

Mikart, LLC ("Mikart"), a leader in formulation development, analytical testing, and finished dose manufacturing, and Benuvia Operations, LLC ("Benuvia"), a CDMO with specialized development and ...

Manufacture drugs in their own parking lot. Mr. Cuban’s Cost Plus Drugs previously launched a Dallas-based manufacturing ...